Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Vancomycin Hydrochloride Patent Expiration

Vancomycin Hydrochloride is Used for treating bacterial infections in the gastrointestinal tract. It was first introduced by Ani Pharmaceuticals Inc in its drug Vancocin Hydrochloride on Apr 15, 1986. Other drugs containing Vancomycin Hydrochloride are Vancomycin Hydrochloride In Plastic Container, Vancomycin Hydrochloride, Firvanq Kit. 34 different companies have introduced drugs containing Vancomycin Hydrochloride.


Vancomycin Hydrochloride Patents

Given below is the list of patents protecting Vancomycin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Vancomycin Hydrochloride US10039804 Glycopeptide compositions Nov 06, 2035 Xellia Pharms Aps
Vancomycin Hydrochloride US10188697 Glycopeptide compositions Nov 06, 2035 Xellia Pharms Aps
Vancomycin Hydrochloride US10849956 Glycopeptide compositions Nov 06, 2035 Xellia Pharms Aps
Vancomycin Hydrochloride US11517609 Glycopeptide compositions Nov 06, 2035 Xellia Pharms Aps
Vancomycin Hydrochloride US11628200 Glycopeptide compositions Nov 06, 2035 Xellia Pharms Aps
Firvanq Kit US10493028 Composition and method for vancomycin oral liquid Mar 13, 2035 Azurity
Firvanq Kit US10688046 Composition and method for vancomycin oral liquid Mar 13, 2035 Azurity
Firvanq Kit US10959946 Composition and method for vancomycin oral liquid Mar 13, 2035 Azurity
Firvanq Kit US10959947 Composition and method for vancomycin oral liquid Mar 13, 2035 Azurity
Firvanq Kit US10959948 Composition and method for vancomycin oral liquid Mar 13, 2035 Azurity
Firvanq Kit US10959949 Composition and method for vancomycin oral liquid Mar 13, 2035 Azurity
Firvanq Kit US11638692 Composition and method for vancomycin oral liquid Mar 13, 2035 Azurity



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Vancomycin Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Vancomycin Hydrochloride.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 15 May, 2024 US10849956
Electronic Review
Critical
 19 May, 2023 US11628200
Email Notification
Critical
 19 May, 2023 US11628200
Miscellaneous Communication to Applicant - No Action Count 18 May, 2023 US11628200
Mail Miscellaneous Communication to Applicant 18 May, 2023 US11628200
Electronic Review
Critical
 21 Apr, 2023 US11628200
Email Notification
Critical
 21 Apr, 2023 US11628200
Mail Miscellaneous Communication to Applicant 21 Apr, 2023 US11628200
Miscellaneous Communication to Applicant - No Action Count 18 Apr, 2023 US11628200
Patent Issue Date Used in PTA Calculation
Critical
 18 Apr, 2023 US11628200


Vancomycin Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Vancomycin Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Vancomycin Hydrochloride. The first generic version for Vancomycin Hydrochloride was by Ani Pharmaceuticals Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Aug 4, 2023.

Given below is the list of companies who have filed for Vancomycin Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE/ML

for solution Prescription ORAL AB Nov 14, 2022
EQ 50MG BASE/ML

for solution Prescription ORAL AB Nov 14, 2022





2. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 250MG BASE/5ML

for solution Prescription ORAL AA Jun 23, 2023


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Brookhaven Amneal Pharmaceuticals of New York, LLC
East Hanover Amneal Pharmaceuticals LLC
Paterson Amneal Pharmaceuticals, Llc
Branchburg Amneal Pharmaceuticals, LLC
Bridgewater Amneal Complex Products Research LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Glasgow Amneal Pharmaceuticals LLC
Piscataway Amneal Pharmaceuticals, LLC
India
Matoda Amneal Pharmaceuticals Private Ltd.
Hyderabad Amneal Oncology Private Limited
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Ahmedabad Amneal Pharmaceuticals Private Ltd.





3. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. All of these versions come by the name VANCOCIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/6ML

for solution Discontinued ORAL N/A Approved Prior to Jan 1, 1982
EQ 250MG BASE/5ML

(reference standard)

for solution Prescription ORAL AA Jul 13, 1983





4. ASPIRO

Aspiro Pharma Ltd has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

injectable Prescription INJECTION AP Jul 6, 2022
EQ 1GM BASE/VIAL

injectable Prescription INJECTION AP Jul 6, 2022


Manufacturing Plant Locations
New

Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.

Country City Firm Name
India
Siddipet (Dist) Aspiro Pharma Limited





5. AVET LIFESCIENCES

Avet Lifesciences Ltd has filed for 4 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10GM BASE/VIAL

injectable Discontinued INJECTION N/A Oct 9, 2013
EQ 5GM BASE/VIAL

injectable Discontinued INJECTION N/A Oct 31, 2013
EQ 1GM BASE/VIAL

injectable Discontinued INJECTION N/A Oct 31, 2013
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Oct 31, 2013





6. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 6 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Mar 29, 2016
EQ 5GM BASE/VIAL

injectable Prescription INJECTION AP Mar 29, 2016
EQ 500MG BASE/VIAL

injectable Prescription INJECTION AP Mar 31, 2016
EQ 1GM BASE/VIAL

injectable Prescription INJECTION AP Mar 31, 2016
EQ 1.25GM BASE/VIAL

powder Prescription INTRAVENOUS AP Aug 4, 2023
EQ 1.5GM BASE/VIAL

powder Prescription INTRAVENOUS AP Aug 4, 2023


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited





7. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 7 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Mar 17, 1987
EQ 1GM BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Jul 31, 1987
EQ 5GM BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Jun 3, 1988
EQ 10GM BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Nov 28, 1997
EQ 250MG BASE

capsule Discontinued ORAL N/A Jun 18, 2012
EQ 125MG BASE

capsule Discontinued ORAL N/A Jun 18, 2012
EQ 750MG BASE/VIAL

injectable Prescription INJECTION AP Aug 17, 2016


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Melrose Park Fresenius Kabi USA LLC
Grand Island Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC





8. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 4 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1GM BASE/VIAL

injectable Prescription INJECTION AP Jan 21, 2016
EQ 500MG BASE/VIAL

injectable Prescription INJECTION AP Jan 21, 2016
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Jun 6, 2023
EQ 5GM BASE/VIAL

injectable Prescription INJECTION AP Jun 6, 2023





9. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 11 different strengths of generic version for Vancomycin Hydrochloride. Out of these eq 500mg base/vial **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** version comes by the name VANCOLED, eq 1gm base/vial **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** version comes by the name VANCOLED, eq 10gm base/vial **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** version comes by the name VANCOLED, eq 5gm base/vial **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** version comes by the name VANCOLED, eq 2gm base/vial **federal register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** version comes by the name VANCOLED. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

injectable Discontinued INJECTION N/A Jul 22, 1986
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

injectable Discontinued INJECTION N/A Mar 30, 1988
EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

injectable Discontinued INJECTION N/A May 11, 1988
EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

injectable Discontinued INJECTION N/A May 11, 1988
EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

injectable Discontinued INJECTION N/A May 11, 1988
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Aug 11, 2020
EQ 1GM BASE/VIAL

injectable Prescription INJECTION AP Aug 11, 2020
EQ 5GM BASE/VIAL

injectable Prescription INJECTION AP Oct 15, 2018
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Oct 15, 2018
EQ 1.25GM BASE/VIAL

powder Prescription INTRAVENOUS AP Jun 29, 2023
EQ 1.5GM BASE/VIAL

powder Prescription INTRAVENOUS AP Jun 29, 2023


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





10. HIKMA PHARMS

Hikma Pharmaceuticals has filed for 1 generic for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 750MG BASE/VIAL

injectable Prescription INJECTION AP Oct 3, 2018





11. HOSPIRA

Hospira Inc has filed for 6 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1GM BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Oct 29, 1992
EQ 500MG BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Oct 29, 1992
EQ 5GM BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Dec 21, 1990
EQ 750MG BASE/VIAL

injectable Prescription INJECTION AP May 27, 2009
EQ 1.5GM BASE/VIAL

(reference standard)

injectable Prescription INJECTION N/A Jul 10, 2020
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Sep 14, 2020


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Clayton Hospira, Inc.
Morgan Hill Hospira Inc
Rocky Mount Hospira, Inc.
Lake Forest Hospira Inc
Mcpherson Hospira, Inc., A Pfizer Company
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





12. HOSPIRA INC

Hospira Inc has filed for 1 generic for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Hospira Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Apr 29, 2009


Manufacturing Plant Locations
New

Hospira Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Hospira Inc as present at those locations.

Country City Firm Name
United States
Lake Forest Hospira Inc
Morgan Hill Hospira Inc





13. KNACK

Knack Pharmaceuticals Inc has filed for 3 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Knack.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 750MG BASE/VIAL

injectable Discontinued INJECTION N/A Feb 15, 2022
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Feb 15, 2022
EQ 1GM BASE/VIAL

injectable Discontinued INJECTION N/A Feb 15, 2022





14. LEDERLE

Lederle Parenterals Inc has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. All of these versions come by the name VANCOLED. Given below are the details of the strengths of this generic introduced by Lederle.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/6ML

for solution Discontinued ORAL N/A Oct 15, 1993
EQ 250MG BASE/5ML

for solution Discontinued ORAL N/A Oct 15, 1993





15. LUPIN LTD

Lupin Ltd has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 250MG BASE

capsule Prescription ORAL AB Jan 28, 2015
EQ 125MG BASE

capsule Prescription ORAL AB Jan 28, 2015


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





16. MEDIMETRIKS PHARMS

Medimetriks Pharmaceuticals Inc has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Medimetriks Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Jun 30, 2008
EQ 1GM BASE/VIAL

injectable Discontinued INJECTION N/A Jun 30, 2008





17. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 5 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5GM BASE/VIAL

injectable Prescription INJECTION AP Jul 27, 2022
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Jul 27, 2022
EQ 1GM BASE/VIAL

injectable Prescription INJECTION AP Jul 28, 2022
EQ 500MG BASE/VIAL

injectable Prescription INJECTION AP Jul 28, 2022
EQ 750MG BASE/VIAL

injectable Prescription INJECTION AP Sep 15, 2022





18. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 4 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

injectable Prescription INJECTION AP Dec 30, 2008
EQ 5GM BASE/VIAL

injectable Prescription INJECTION AP Dec 30, 2008
EQ 1GM BASE/VIAL

injectable Prescription INJECTION AP Dec 30, 2008
EQ 10GM BASE/VIAL

(reference standard)

injectable Prescription INJECTION AP Sep 19, 2011





19. ORIENT PHARMA CO LTD

Orient Pharma Co Ltd has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Orient Pharma Co Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 250MG BASE

capsule Prescription ORAL AB Apr 29, 2019
EQ 125MG BASE

capsule Prescription ORAL AB Apr 29, 2019





20. PAI HOLDINGS PHARM

Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 125MG BASE

capsule Discontinued ORAL N/A Apr 9, 2012
EQ 250MG BASE

capsule Discontinued ORAL N/A Apr 9, 2012





21. PHARMACIA AND UPJOHN

Pharmacia And Upjohn Co has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. All of these versions come by the name VANCOR. Given below are the details of the strengths of this generic introduced by Pharmacia And Upjohn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1GM BASE/VIAL

injectable Discontinued INJECTION N/A Aug 1, 1988
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Aug 1, 1988





22. SAGENT PHARMS

Sagent Pharmaceuticals Inc has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sagent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5GM BASE/VIAL

injectable Prescription INJECTION AP Aug 10, 2012
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Sep 2, 2014





23. SAMSON MEDCL

Samson Medical Technologies Llc has filed for 1 generic for Vancomycin Hydrochloride. This eq 100gm base version comes by the name VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Samson Medcl.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100GM BASE

powder Prescription INTRAVENOUS N/A Jan 6, 2016





24. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Apr 27, 2010
EQ 1GM BASE/VIAL

injectable Discontinued INJECTION N/A Apr 27, 2010


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





25. SANDOZ INC

Sandoz Inc has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10GM BASE/VIAL

injectable Discontinued INJECTION N/A Aug 10, 2012
EQ 5GM BASE/VIAL

injectable Discontinued INJECTION N/A Aug 10, 2012


Manufacturing Plant Locations
New

Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.

Country City Firm Name
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc





26. SLATE RUN PHARMA

Slate Run Pharmaceuticals Llc has filed for 4 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Slate Run Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

injectable Prescription INJECTION AP Jun 12, 2019
EQ 1GM BASE/VIAL

injectable Prescription INJECTION AP Jun 12, 2019
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Nov 18, 2021
EQ 5GM BASE/VIAL

injectable Prescription INJECTION AP Nov 18, 2021





27. STERISCIENCE SPECLTS

Steriscience Specialities Pte Ltd has filed for 5 different strengths of generic version for Vancomycin Hydrochloride. All of these versions come by the name VANCOCIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Steriscience Speclts.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

injectable Discontinued INJECTION N/A Nov 17, 1987
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Mar 13, 1987
EQ 1GM BASE/VIAL

injectable Discontinued INJECTION N/A Mar 13, 1987
EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

injectable Discontinued INJECTION N/A Nov 17, 1987
EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

injectable Discontinued INJECTION N/A Nov 17, 1987





28. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 250MG BASE

capsule Prescription ORAL AB Apr 9, 2012
EQ 125MG BASE

capsule Prescription ORAL AB Apr 9, 2012


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Bangalore Strides Pharma Science Limited
Puducherry Strides Pharma Science Limited





29. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5GM BASE/VIAL

injectable Discontinued INJECTION N/A Dec 23, 2015
EQ 10GM BASE/VIAL

injectable Discontinued INJECTION N/A Dec 23, 2015
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Dec 23, 2015
EQ 1GM BASE/VIAL

injectable Discontinued INJECTION N/A Dec 23, 2015





30. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 125MG BASE

capsule Discontinued ORAL N/A Apr 9, 2012
EQ 250MG BASE

capsule Discontinued ORAL N/A Apr 9, 2012





31. XELLIA PHARMS APS

Xellia Pharmaceuticals Aps has filed for 4 different strengths of generic version for Vancomycin Hydrochloride. Given below are the details of the strengths of this generic introduced by Xellia Pharms Aps.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 500MG BASE/VIAL

injectable Discontinued INJECTION N/A Sep 9, 2015
EQ 1GM BASE/VIAL

injectable Discontinued INJECTION N/A Sep 9, 2015
EQ 5GM BASE/VIAL

injectable Prescription INJECTION AP Dec 28, 2015
EQ 10GM BASE/VIAL

injectable Prescription INJECTION AP Dec 28, 2015